Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CRDL.TOthis companyCardiol Therapeutics Inc.	CA$1.44	-3.36×	6.37×	0×	-2.71×	-83.2%	0.0%	0.0%	0.0%	-189.2%	-190.6%	-21.0%	0.01×	0.62×	0×	4.16×	0.0%	2	5.98	2	C
BNXT.CNBioNxt Solutions Inc.	CA$0.26	-10.76×	-8.07×	0×	-13.49×	-121.0%	0.0%	0.0%	0.0%	75.0%	172.2%	-6.9%	-0.63×	-0.98×	-4.2×	0.05×	0.0%	3	-88.15	2	C
HLS.TOHLS Therapeutics Inc.	CA$4.41	-8.77×	1.8×	1.96×	8.25×	26.6%	42.5%	-7.4%	-22.4%	-20.5%	-3.5%	14.3%	0.81×	2.11×	-0.58×	1.11×	0.0%	5	-1.12	2	C+
MSCL.TOSatellos Bioscience Inc.	CA$10.15	-4.58×	4.17×	0×	-3.93×	-93.6%	0.0%	0.0%	0.0%	-91.3%	-97.1%	-20.8%	0×	0.36×	0×	7.77×	0.0%	1	16.77	1	C-
RX.VBioSyent Inc.	CA$18.07	15.91×	3.46×	3.33×	10.19×	15.5%	74.6%	26.3%	20.9%	21.7%	20.0%	6.7%	0.02×	-1.6×	229.23×	5.51×	1.6%	5	10.66	4	A
ZEN.VZentek Ltd.	CA$0.54	-7.81×	7.78×	459.28×	-7.46×	-104.2%	-3785.5%	-6521.6%	-5882.6%	-99.7%	-92.4%	-7.6%	0.2×	-0.06×	-37.44×	0.64×	0.0%	2	2.33	1	C-
Peer median	—	-7.81×	3.46×	1.96×	-3.93×	-93.6%	0.0%	0.0%	0.0%	-20.5%	-3.5%	-6.9%	0.02×	-0.06×	-0.58×	1.11×	0.0%	3	2.33	2	—